Evan Jones is the Founder, Executive Chairman, and Managing Member of jVEN Capital, a Potomac. See sector focus and contact routes.
Evan Jones is the Founder, Executive Chairman, and Managing Member of jVEN Capital, a Potomac, MD-based venture capital firm he established in 2007 after serving as CEO of OpGen and co-founding Digene Corp. His investment thesis targets life sciences companies in personalized medicine, digital health, genetics, and medical devices, with a focus on growth equity and venture stages. The firm does not publicly disclose typical check sizes or whether Jones leads or follows deals, so those specifics remain unverified. Notable portfolio companies include Veracyte, where Jones has served on the board since 2008, and OpGen, which he led as CEO from 2013 to 2020. Jones also co-founded Digene Corp. in 1987, a molecular diagnostics company focused on women’s health, reflecting his deep operational background in the sector. While he has no widely published public writing or distinctive investor philosophy documented in available sources, his 30+ years of operating and investment experience in life sciences shape his approach.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Potomac.
Investors like Evan Jones · Full investor directory · Investor access · Company funding database